Interpreting the Economic Value of Docetaxel, Platinum, and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: The Importance of Decision Context, Utility Timing, and Treatment Burden
Interpreting the Economic Value of Docetaxel, Platinum, and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: The Importance of Decision Context, Utility Timing, and Treatment Burden. // Value in Health. – URL: https://www.sciencedirect.com/science/article/pii/S1098301526025180?dgcid=rss_sd_all
Interpreting the Economic Value of Docetaxel, Platinum, and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: The Importance of Decision Context, Utility Timing, and Treatment Burden. Value in Health. https://www.sciencedirect.com/science/article/pii/S1098301526025180?dgcid=rss_sd_all
“Interpreting the Economic Value of Docetaxel, Platinum, and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: The Importance of Decision Context, Utility Timing, and Treatment Burden.” Value in Health.
@article{article91148,
title = {Interpreting the Economic Value of Docetaxel, Platinum, and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: The Importance of Decision Context, Utility Timing, and Treatment Burden},
journal = {Value in Health},
url = {https://www.sciencedirect.com/science/article/pii/S1098301526025180?dgcid=rss_sd_all}
}
Abstract Aim Discretionary foods and beverages contribute to poor diet quality and chronic disease. In Australia, intake exceeds dietary guideline recommendations and is unlikely to improve without substantial intervention. We examined...
ABSTRACT Background Ultra‐processed foods (UPFs) are a leading contributor to diet‐related chronic disease and socio‐ecological harm. Despite increasing recognition of these impacts, regulatory responses remain fragmented, focused on...